🇺🇸 FDA
Patent

US 10251909

Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension

granted A61KA61K31/19A61K33/00

Quick answer

US patent 10251909 (Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension) held by The Board of Regents of the University of Texas System expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/19, A61K33/00, A61K33/06, A61K45/06